I wouldn't listen to him anyway--one of the reasons I invested in NVIV is the outstanding team they have assembled-especially Dr. Robert Langer---just read the recent NY Times article on his work (11/24/12)--he has helped start 25 companies and has 811 patents (issued or pending). In fact more than 250 companies have licensed or sublicensed Langer Lab patents. He wouldn't be sitting on the board of directors at NVIV if he thought their work was going nowhere--when it comes to presenting your work to the FDA having Dr. Langer on your team will almost guarantee success---so whatever tdarren argues against NVIV doesn't mean anything to me
Good point - Dr. Langer, with his NY Times article on November 24, 2012, is on the record as helping start 25 companies, with a total of 811 patents - current or pending. Amazing that 250 companies have licensed his patents. I agree he wouldn't be on the BOD unless this company had a very high probability of success. Who would know better than the ex-chairman of the FDA's science board.